Status:
SUSPENDED
Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia
Lead Sponsor:
Zhu Dian
Conditions:
Schizophrenia and Related Disorders
Medication Adherence
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study explores the potential of an interactive narrative game to enhance medication adherence among stable schizophrenia patients. Employing participatory design methods, game's development and t...
Detailed Description
Our game design is inspired by Cognitive Behavioral Therapy (CBT), specifically the autonomic engagement and emotion regulation for the treatment of stable schizophrenic patients. This design aims to ...
Eligibility Criteria
Inclusion
- Stable Phase Schizophrenia
- on long-term medication
- medication adherence was problematic
Exclusion
- Serious Schizophrenia
- Lack of basic cognitive abilities
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06175559
Start Date
September 1 2023
End Date
September 1 2025
Last Update
July 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200240